Volume: 8 Issue 11 [November 2025]

Article:Regulatory Approval to Community Care: An Integrated Pharmaceutical and Delivery Model for Cervical Cancer Elimination in Bangladesh

Author: Mst Surovey Sultana Mukta , Mst Yeasmin Ila

Volume: Vol 8, Issue 11; November 2025

DOI: North American Academic Research, 8(11), 372-376. doi: https://doi.org/10.5281/zenodo.17795612

Abstract: Cervical cancer (CC) continues to be a significant public health problem in Bangladesh, with high mortality rates (ASMR 6.7/100,000) and considerable disease burden (8,268 cases in 2020). The present work introduces a comprehensive plan involving pharmaceutical regulatory framework (70% focus) and an optimized primary healthcare delivery system (30% focus) to help Bangladesh reach the WHO’s 2030 90-70-90 elimination targets. The Pharmaceutical Pillar must address the procurement, quality control, cold chain integrity, and regulatory fast-tracking of HPV vaccines and diagnostics for this. The Delivery Pillar, which should be led by the nursing cadre, must put into operation these instruments throughout the community, that is, through outreach, specialized training, and a decentralized screen-and-treat protocol at the Upazila Health Complex (UHC) level to fight the pervading issue of Loss to Follow-Up (LTFU) burden. The main factor to succeed in the elimination is through the direct linking of pharmaceutical innovation to the empowered and community-based nursing practice.

Comments